期刊文献+

马来酸曲美布汀大鼠肠吸收动力学研究 被引量:1

Kinetics of trimebutine maleate absorption in rat intestines
下载PDF
导出
摘要 目的研究马来酸曲美布汀在大鼠不同肠段的吸收动力学特征,为其剂型设计提供生物药剂学依据。方法采用大鼠在体肠循环法研究马来酸曲美布汀的吸收部位和吸收动力学特征,利用紫外-可见分光光度法和反相-高效液相色谱法分别测定肠循环液中酚红和甲硝唑浓度。结果马来酸曲美布汀在十二指肠、空肠、回肠及结肠中的吸收速度常数分别为0.230±0.023、0.084±0.051、0.202±0.021、0.170±0.038(h-1),不同药物浓度(10、20、25μg/ml)在小肠的吸收速率常数分别为0.393±0.044、0.354±0.017、0.365±0.075(h-1),胆总管引流与不引流时药物在小肠的吸收速率常数分别为0.354±0.017、0.370±0.014(h-1)。结论马来酸曲美布汀在全肠段中均有吸收,吸收在10~25μg/ml浓度范围内符合一级动力学特征,吸收机制为被动扩散,胆汁排泄对药物吸收影响不大。 Objective To investigate the absorption kinetics of trimebutine maleate (TMB) at different intestinal segments in rats, and provide biological pharmaceutical basis for dosage design. Methods The absorption kinetics of TMB at different intestinal segments in rats was studied by in situ recirculation. UV and RP-HPLC were used to determine the concentrations of phenol red and TMB, respectively. Results The apparent absorption constants (ka) in duodenum, jejunum, ileum and colon were 0.230±0.023, 0.084±0,051, 0.202±0.021, 0.170±0.038(h^-1), respectively. Intestinal ka of TMB at different concentrations (10, 20, 25 μg/ml) were 0.393±0.044, 0.354±0.017, 0.365±0.075(h^-1), respectively, ka of TMB with or without bile duct-drainage were 0.354±0.017, 0.370±0.014(h^-1), respectively. Conclusion TMB appeared absorbable in all segments of rat intestine. The intestinal absorption rate of TMB followed first-order kinetics and was consistent with passive transportation over the concentration range of 10-25 μg/ml. The intestinal absorption of TMB was not influenced by excretion of bile.
出处 《中国药物与临床》 CAS 2009年第4期297-300,共4页 Chinese Remedies & Clinics
基金 山西省回国留学人员科研项目(2005029) 太原市科技明星专项基金(07020425) 山西医科大学学生创新项目基金(2007076)
关键词 肠吸收 色谱法 高压液相 马来酸曲美布汀 Trimebutine maleate Chromatography,high pressure liquid Intestinal absorption
  • 相关文献

参考文献7

二级参考文献39

共引文献49

同被引文献11

  • 1白敏,丁平田,谢俊霞,魏薇.石杉碱甲大鼠在体肠吸收动力学研究[J].中南药学,2005,3(4):211-213. 被引量:13
  • 2郭歆,曹伟,程泽能,黄志壮,李焕德.齐墩果酸大鼠肠吸收动力学[J].中南药学,2007,5(3):216-219. 被引量:17
  • 3Sato T,Kawamoto A,Tamura A,et al.Mechanism of antioxi-dant action of pueraria glycoside (PG) -1 (an isoflavonoid) and mangiferin (a xanthonoid)[J].Chem Pharn Bull (Tokyo),1992,40 (3):721-724.
  • 4Ichiki H,Miura T,Kubo M,et al.New antidiabetic compounds,mangiferin and its glucoside[J].Biol Pharm Bull,1998,21(12):1389-1390.
  • 5Yoshimi N,Matsunaga K,Katayama M,et al.The inhibitory effects of mangiferin,a naturally occurring glucosylxanthone,in bowel carcinogenesis of male F344 rats[J].Cancer Lett,2001,163 (2):163-70.
  • 6Martinez G,Giuliani A.Leon OS,et al.Effect of Mangifera India L.extract (QF808) on protein and hepatic microsome peroxidation[J].Phytother Res,2001,15 (7):581-585.
  • 7Muruganandan S,Gupta S,Kataria M,et al.Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats[J].Toxicology,2002,176 (3):165-173.
  • 8LI JT,LI LJ,LI TS,et al.U hrasound promoted synthesis of 5-substiuted and 5,5-distitued hydatoins[J]India J Cham,1998,10(1):63-73.
  • 9刘睿,刘志东,张伯礼,高秀梅,张欣华.丹酚酸B大鼠在体肠吸收研究[J].中国新药杂志,2008,17(10):852-854. 被引量:31
  • 10洪丽娟,潘卫三,潘裕生,周彩红,颜廷旭,聂淑芳.尼美舒利大鼠在体肠吸收动力学[J].中国新药与临床杂志,2009,28(2):130-133. 被引量:12

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部